Sort   by:  
 Page size 
UnknownPhase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study.
Not available
S-EPMC3139373 | biostudies-literature
UnknownValidating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry.
Not available
S-EPMC10830583 | biostudies-literature
Unknown2023 Canadian Surgery Forum: Sept. 20-23, 2023.
Not available
S-EPMC10718225 | biostudies-literature
UnknownLong-Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons.
Not available
S-EPMC12623843 | biostudies-literature
UnknownPatterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry.
Not available
S-EPMC10518516 | biostudies-literature
UnknownGlioma progression is shaped by genetic evolution and microenvironment interactions.
Not available
S-EPMC9189056 | biostudies-literature
UnknownDevelopment and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
Not available
S-EPMC4380415 | biostudies-literature
UnknownSociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS).
Not available
S-EPMC12451849 | biostudies-literature
UnknownInterleukin-2 therapy in patients with HIV infection.
Not available
S-EPMC2869083 | biostudies-literature
UnknownSeverity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
Not available
S-EPMC4309077 | biostudies-literature
Sort   by:  
 Page size